Abstract:Introduction MicroRNA-21 (miR-21) has been implicated as a regulator of fibrosis. Inhibitors of miR-21 are currently undergoing clinical trials. Our aim was to explore mechanisms of how miR-21 inhibition attenuates fibrosis using a proteomics approach. Methods and results Primary murine cardiac fibroblasts (CF) were transfected with miR-21 mimics and inhibitors. In line with previous reports, miR-21 overexpression increased CF proliferation (n=4 vs. 4; p<0.0001 for 2-way ANOVA). Unexpectedly, proteomic analysis revealed limited effects on extracellular matrix (ECM) secretion. Similarly, the ECM protein composition of hearts from miR-21 null mice was similar to wild-type controls. Thus, we searched for additional explanations as to how miR-21 might regulate fibrosis. In the community-based Bruneck study (n=671), we compared circulating miR-21 with a proteomic panel of 229 proteins associated with cardiovascular disease. Several platelet-derived pro-fibrotic factors significantly correlated with plasma miR-21 levels, including the latency-associated peptide of TGF-β1 (Pearson r 0.68; q<0.0001). Argonaute2 immunoprecipitation demonstrated enrichment of miR-21 in a human megakaryoblastic cell line. Furthermore, TGF-β1 was abundant in megakaryocytes as demonstrated by immunofluorescence staining of murine bone marrow. Platelet immunodepletion in mice (n=5 vs. 7 for control and anti-CD42b antibody injection, respectively) revealed a strong platelet dependency of plasma TGF-β1 levels (fold change: 2.37; p=0.003). Correlation of miR-21 with total TGF-β1 was confirmed in humans by ELISA measurements in platelet-poor plasma collected during the Bruneck 2015 follow-up (n=332; Pearson r: 0.63; q<0.0001). When mice were treated with antagomiR-21, no differences were observed in the platelet count or in their aggregation response to different agonists. However, a proteomics analysis of the platelet releasate revealed TGF-β1 as differentially regulated. An attenuated TGF-β1 release after antagomiR-21 treatment (n=5 vs. 5 for control and antagomiR-21) was validated in platelets activated with collagen and a thrombin receptor-activating peptide (p=0.004 and 0.002, respectively, for 2-way ANOVA). Mechanistically, Wiskott-Aldrich Syndrome protein, a negative regulator of platelet TGF-β1 secretion, was identified as a direct target of miR-21. Conclusions This study reports a previously unrecognised effect of miR-21 inhibition on platelet TGF-β1 release. This novel systemic effect of miR-21 on platelets may contribute to the anti-fibrotic effects of miR-21 inhibitors.

Abstract 174: miR30c Regulates Plasminogen Activator Inhibitor-1 In Platelet

Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets

Mir-301A-3p Promotes Hepatic Stellate Cells Activation and Liver Fibrogenesis Via Regulating PTEN/PDGFR-β.

Effects of miR-30 c on viability and migratory ability of HUVECs by tar-geting PAI-1

82 Microrna-21 Regulates Transforming Growth Factor Beta-1 Release from Platelets

Abstract 300: MicroRNA-21 Affects Platelets and Their Releasate: A Novel Mechanism for the Anti-Fibrotic Effects of MicroRNA-21 Inhibition

Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition

Upregulation of microRNA-30a in peripheral blood mononuclear cells from patients with immune thrombocytopenic purpura and its clinical significance

MicroRNAs 10a and 10b Regulate the Expression of Human Platelet Glycoprotein Ibα for Normal Megakaryopoiesis

Platelets-Derived Mir-200A-3p Modulate the Expression of ET-1 and VEGFA in Endothelial Cells by Targeting MAPK14.

Abstract 383: Paired Immunoglobin-Like Receptor B Regulates Platelet Activation

The Emerging Role of Mir-223 in Platelet Reactivity: Implications in Antiplatelet Therapy

Platelet Microparticles-Containing Mir-4306 Inhibits Human Monocyte-Derived Macrophages Migration Through VEGFA/ERK1/2/NF-κB Signaling Pathways

Inhibition of profibrotic microRNA-21 affects platelets and their releasate

Modulation Of Platelet Activation And Thrombus Formation Using A Pan-Pi3k Inhibitor S14161

Decreased Platelet Mir-199A-5p Level Might Lead to High On-Clopidogrel Platelet Reactivity in Patients with Coronary Artery Disease

Circulating Mir-30C As a Predictive Biomarker of Type 2 Diabetes Mellitus with Coronary Heart Disease by Regulating PAI-1/VN Interactions.

Platelet microRNAs and their emerging roles in platelet production and activation

Platelets in Acute Coronary Syndrome Patients with High Platelet Reactivity after Dual Antiplatelet Therapy Exhibit Upregulation of Mir-204-5p.

Plasma Let-7I and Mir-15A Expression Are Associated with the Effect of Recombinant Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke Patients.

Platelet-derived exosomes regulate endothelial cell inflammation and M1 macrophage polarization in coronary artery thrombosis via modulating miR-34a-5p expression